Free Trial
OTCMKTS:CRLBF

Cresco Labs (CRLBF) Stock Price, News & Analysis

Cresco Labs logo
$0.66 -0.04 (-5.49%)
As of 07/11/2025 03:59 PM Eastern

About Cresco Labs Stock (OTCMKTS:CRLBF)

Key Stats

Today's Range
$0.65
$0.71
50-Day Range
$0.43
$0.89
52-Week Range
$0.43
$2.05
Volume
1.00 million shs
Average Volume
534,508 shs
Market Capitalization
$322.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Buy

Company Overview

Cresco Labs Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
11th Percentile Overall Score

CRLBF MarketRank™: 

Cresco Labs scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Cresco Labs are expected to grow in the coming year, from ($0.20) to ($0.05) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cresco Labs is -2.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cresco Labs is -2.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cresco Labs has a P/B Ratio of 0.83. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Cresco Labs' valuation and earnings.
  • Percentage of Shares Shorted

    0.14% of the float of Cresco Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    Cresco Labs has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cresco Labs has recently decreased by 1.36%, indicating that investor sentiment is improving.
  • Dividend Yield

    Cresco Labs does not currently pay a dividend.

  • Dividend Growth

    Cresco Labs does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.14% of the float of Cresco Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    Cresco Labs has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cresco Labs has recently decreased by 1.36%, indicating that investor sentiment is improving.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Cresco Labs this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for CRLBF on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days. This is a decrease of -83% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cresco Labs insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Only 0.05% of the stock of Cresco Labs is held by institutions.

  • Read more about Cresco Labs' insider trading history.
Receive CRLBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter.

CRLBF Stock News Headlines

CRLBF - Cresco Labs Inc Financials - Morningstar
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
CRLBF Cresco Labs Inc. - Seeking Alpha
See More Headlines

CRLBF Stock Analysis - Frequently Asked Questions

Cresco Labs' stock was trading at $0.9137 at the beginning of the year. Since then, CRLBF shares have decreased by 28.1% and is now trading at $0.6574.

Cresco Labs Inc. (OTCMKTS:CRLBF) released its earnings results on Friday, May, 30th. The company reported ($0.04) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by $0.01. The company had revenue of $165.76 million for the quarter, compared to analysts' expectations of $164.37 million. Cresco Labs had a negative net margin of 11.86% and a negative trailing twelve-month return on equity of 21.77%.

Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/30/2025
Today
7/11/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CRLBF
CIK
1832928
Fax
N/A
Employees
2,900
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.24)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$74.44 million
Net Margins
-11.86%
Pretax Margin
-3.89%
Return on Equity
-21.77%
Return on Assets
-6.00%

Debt

Debt-to-Equity Ratio
1.63
Current Ratio
2.75
Quick Ratio
1.98

Sales & Book Value

Annual Sales
$724.34 million
Price / Sales
0.45
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.79 per share
Price / Book
0.83

Miscellaneous

Outstanding Shares
491,020,000
Free Float
N/A
Market Cap
$322.80 million
Optionable
Not Optionable
Beta
1.40
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (OTCMKTS:CRLBF) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners